These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4192950)

  • 1. Oral dosage form design and its influence on dissolution rates for a series of drugs.
    Hom FS; Miskel JJ
    J Pharm Sci; 1970 Jun; 59(6):827-30. PubMed ID: 4192950
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting the dissolution rate of medicaments from tablets. I. In vitro dissolution rate of commercial phenobarbital tablets.
    Jacob JT; Plein EM
    J Pharm Sci; 1968 May; 57(5):798-801. PubMed ID: 5657538
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice.
    Solvang S; Finholt P
    J Pharm Sci; 1970 Jan; 59(1):49-52. PubMed ID: 5411324
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultraviolet spectrophotometric determination of propylthiouracil in assays and dissolution studies of tablets and capsules.
    Hom FS; Veresh SA; Miskel JJ
    J Assoc Off Anal Chem; 1971 Nov; 54(6):1420-2. PubMed ID: 5151709
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous dissolution profiles of two drugs, sulfadiazine-trimethoprim and amitriptyline-perphenazine, in solid oral dosage forms by a FIA manifold provided with a single spectrophotometric detector.
    Gálvez AM; Mateo JV; Martínez Calatayud J
    J Pharm Biomed Anal; 2002 Oct; 30(3):535-45. PubMed ID: 12367678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DRUG DOSAGE. A REVIEW OF A PROBLEM IN PEDIATRICS.
    STICKLER GB
    Clin Pediatr (Phila); 1964 Oct; 3():574-7. PubMed ID: 14220135
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiologic surface-active agents and drug absorption. IV. Effect of pre-micellar concentrations of surfactant on dissolution rate.
    Weintraub H; Gibaldi M
    J Pharm Sci; 1969 Nov; 58(11):1368-72. PubMed ID: 4900222
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissolution, stability, and absorption characteristics of dicumarol in polyethylene glycol 4000 solid dispersions.
    Ravis WR; Chen CY
    J Pharm Sci; 1981 Dec; 70(12):1353-7. PubMed ID: 6172580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.
    Siewert M; Dressman J; Brown CK; Shah VP; ;
    AAPS PharmSciTech; 2003; 4(1):E7. PubMed ID: 12916916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of the absorption spectroscopy in the analysis of drugs from the group of estrogens and their synthetic substitutes].
    Kovalenko LI
    Farmatsiia; 1968; 17(3):87-90. PubMed ID: 4324099
    [No Abstract]   [Full Text] [Related]  

  • 11. The purity of phenylbutazone raw material and solid dosage forms as monitored by gas-liquid chromatography.
    Watson JR; Matsui F; Lawrence RC; McConnell PM
    J Chromatogr; 1973 Feb; 76(1):141-7. PubMed ID: 4686932
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissolution kinetics of drugs in human gastric juice--the role of surface tension.
    Finholt P; Solvang S
    J Pharm Sci; 1968 Aug; 57(8):1322-6. PubMed ID: 5677333
    [No Abstract]   [Full Text] [Related]  

  • 13. New in vitro dissolution test apparatus.
    Nasir SS; Wilken LO; Nasir SM
    J Pharm Sci; 1979 Feb; 68(2):177-81. PubMed ID: 423087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution of poorly water-woluble drugs. II. Excipient dilution and force of compression effects on tablets of a quinazolinone compound.
    Hirschorn JO; Kornblum SS
    J Pharm Sci; 1971 Mar; 60(3):445-8. PubMed ID: 5572125
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
    Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
    Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of phenylbutazone in plasma.
    Jähnchen E; Levy G
    Clin Chem; 1972 Sep; 18(9):984-6. PubMed ID: 5052102
    [No Abstract]   [Full Text] [Related]  

  • 19. [The biological availability of digitoxin].
    Vöhringer HF; Wogenstein HM; Rietbrock N
    Fortschr Med; 1977 Oct; 95(38):2323-5, 2328-31. PubMed ID: 914188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dosage forms. IV. Studies on commercial phenylbutazone tablet dosage forms.
    Razdan B; Paradkar AR
    Drug Dev Ind Pharm; 1998 Jul; 24(7):599-604. PubMed ID: 9876503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.